这使百 时美施贵宝在产品推出后的头2 年内实现了博路定(Baraclude)上市效果的最大化。 总而言之，博路定(Baraclude)作为“市场制造者”，制定了令人瞩目的蓝图，成功推出了产品。
基于180个网页-相关网页
恩替卡韦（Baraclude）是美国百时美施贵宝公司自主研发的鸟嘌呤核苷类似物口服药。
基于152个网页-相关网页
Baraclude - After Plavix, Baraclude is the next significant challenge that BMS will have to face immediately.
FORBES: Looking At Bristol-Myers Squibb's Major Patent Expiries That Will Drag On Growth
Baraclude is approved in the United States to treat patients with chronic hepatitis B in adults who have active virus and liver damage.
FORBES: Bristol-Myers Squibb Hit With Surprise Patent Loss
Entecavir is the active ingredient in Baraclude.
应用推荐
模块上移
模块下移
不移动